Vanda Pharmaceuticals earnings were -$18.9M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest VNDA earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$4.9M, down 7.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VNDA reported annual earnings of -$18.9M, with -853.3% growth. The next VNDA earnings date is May 6, 2025.
Vanda Pharmaceuticals Earnings Reports & History FAQ
What were Vanda Pharmaceuticals's earnings last quarter?
On VNDA's earnings call on Invalid Date, Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q4 2024 earnings per share (EPS) of -$0.09, up 80% year over year. Total VNDA earnings for the quarter were -$4.91 million. In the same quarter last year, Vanda Pharmaceuticals's earnings per share (EPS) was -$0.05.
The next VNDA earnings call is Invalid Date. Add VNDA to your watchlist to be reminded of Vanda Pharmaceuticals's next earnings date.
Is Vanda Pharmaceuticals profitable or losing money?
As of the last Vanda Pharmaceuticals earnings report, Vanda Pharmaceuticals is currently losing money. Vanda Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$18.90 million, a 853.29% decrease year over year.
What was VNDA's earnings growth in the past year?
As of Vanda Pharmaceuticals's earnings date in Invalid Date, Vanda Pharmaceuticals's earnings has grown year over year. VNDA earnings in the past year totalled -$18.90 million.
What are Vanda Pharmaceuticals's earnings expectations?
The current EPS estimate for Vanda Pharmaceuticals's earnings report in Invalid Date is $0.05.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.